QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
NASDAQ:MKUL

Molekule Group (MKUL) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.01
$0.21
52-Week Range
N/A
Volume
8.74 million shs
Average Volume
867,711 shs
Market Capitalization
$1.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MKUL stock logo

About Molekule Group Stock (NASDAQ:MKUL)

Molekule Group, Inc., an interior space air purification technology company, provides air purification solutions for hospitals and other healthcare facilities. The company offers interior air sterilization and disinfection products for the eradication of harmful airborne pathogens, including COVID-19. Its air hygiene product, Purgo (pure-go), a medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology applied in any indoor space, including in hospitals, offices, and elevators. The company's Purgo products feature SteriDuct, a proprietary germicidal technology that work to equipment and devices to reduce the exposure of occupants of interior spaces to airborne particles and pathogens; Air Mini+, a direct-to-consumer air purifier, which features include a particle sensor, five fan speeds, and automatic fan speed adjustment through the product's auto protect mode; Air Pro, a direct-to-consumer and business-to-business product for rooms of up to 1,000 square feet; and Air Pro Rx, a medical-grade purifier designed for traffic areas in healthcare facilities for rooms more than 600 square feet. It also offers PECO-HEPA Tri-Power filter; Molekule App, a mobile application that provides a 28 day look back of IAQ trends sensed by the Air Pro air purifier, breaking down pollutants detected, including VOCs, and pollutants that range from PM 1 to PM 10 in size; and Molekule Air Platform, a dashboard that allows data from multiple air purifiers and controls to be accessed in one interface. The company was formerly known as AeroClean Technologies, Inc. and changed its name to Molekule Group, Inc. in January 2023. Molekule Group, Inc. was founded in 2011 and is headquartered in Palm Beach Gardens, Florida. On October 3, 2023, Molekule Group, Inc. along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Florida.


MKUL Stock News Headlines

Molekule Group Inc (MKULQ)
Molekule Group Inc MKULQ
Disturbing Truth About Biden's New Program To Seize Your Cash
A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
Molekule Group, Inc. (MKUL)
Claim $10,000 In FREE silver In 2024
Thanks to forgotten 50-year-old legislation, often ignored by investment advisors, gold bugs, and silver hounds…You can now collect $10,000 or more in free silver. Millions of Americans know NOTHING about this…Because it exploits a “glitch” in the IRS tax code that helps protect your retirement...While paying ZERO TAXES & PENALTIES to do it. That’s why you need to see this NOW.
Molekule Reports Second Quarter 2023 Financial Results
Molekule Group Inc (MKUL)
8-K: Molekule Group, Inc.
Molekule Group announces $10M private placement
See More Headlines
Receive MKUL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Molekule Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
2/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Blowers & fans
Sub-Industry
N/A
Current Symbol
NASDAQ:MKUL
Fax
N/A
Employees
91
Year Founded
N/A

Profitability

Net Income
$-6,170,000.00
Net Margins
-153.26%
Pretax Margin
-154.98%

Debt

Sales & Book Value

Annual Sales
$21.74 million
Book Value
$1.27 per share

Miscellaneous

Free Float
20,862,000
Market Cap
$1.88 million
Optionable
Not Optionable
Beta
-5.01
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Dr. Amin J. Khoury Ph.D. (Age 84)
    Co-Founder & Chairman
  • Mr. Jason DiBona (Age 52)
    Chief Exec. Officer
    Comp: $412.45k
  • Dr. David L. Helfet M.D. (Age 76)
    Co-Founder, Chief Medical Officer & Independent Director
  • Mr. Ryan Tyler (Age 39)
    Chief Financial Officer
    Comp: $371k














MKUL Stock Analysis - Frequently Asked Questions

Should I buy or sell Molekule Group stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Molekule Group in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MKUL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MKUL, but not buy additional shares or sell existing shares.
View MKUL analyst ratings
or view top-rated stocks.

This page (NASDAQ:MKUL) was last updated on 2/22/2024 by MarketBeat.com Staff